CYSTINOSIS TREATMENT MARKET ANALYSIS

Cystinosis Treatment Market, by Treatment (Cysteine Depleting Therapy, Symptomatic Therapy, and Renal transplantation), by End User (Hospitals, Specialty Clinics, and Others) and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI1660
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Cystinosis Treatment Market Competitive Landscape

Key players operating in the cystinosis treatment market include Avrobio, Inc., Gilead, Mylan N.V., Novartis AG, and Orizon Pharma Plc. Companies in the cystinosis treatment market are focusing on new product development to gain major revenue share. For instance, Avrobio Inc. is planing to initiate clinical development of two gene therapy candidates for cystinosis and Gaucher disease by mid-2019.